Amrize's guidance miss and volume falling behind CRH's margin expansion prompted analyst commentary.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amrize's guidance miss and volume falling behind CRH's margin expansion prompted analyst commentary.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- Investing.comAmrize shares tumble 10% on big guidance miss, disappointing Q2 print Investing.com -- Amrize AG (NYSE:AMRZ) (SIX:AMRZ) saw its shares slump more than 10% in premarket trading Thursday after it repor